Tp,
Can you post a link to the study that you referenced?
From what I've now read, ivermectin inhibits replication of the virus
in lab trials at concentrations that are significantly higher than what is approved for human use.
However, the results of a clinical trial on ~400 adult humans (200 given ivermectin, 198 given a placebo) with mild COVID-19 showed that ivermectin did not produce a significant difference in duration of symptoms vs. the placebo group. In the conclusion, the authors of the study said:
"
[FONT="]Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.[/FONT]"
https://jamanetwork.com/journals/jama/fullarticle/2777389
Kindest regards,
Kantuck